Alonso Lab

Weill Medical Coll of Cornell Univ

INTERNAL MEDICINE/MEDICINE

New York · United States

NIH-funded
Rate this labNo reviews yet — be the first.

Research focus

NIH R01 · 2024

Benefits and harms of activating ATF6 in beta cells

ABSTRACT Pancreatic beta cell insulin production is the critical lynchpin that determines diabetes resistance or susceptibility. ER stress is one cause of beta cell dysfunction and failure, not only in T2D but also in T1D and some forms of monogenic diabetes. Many published reports show that the ATF6 pathway, one of three principal ER stress response pathways, plays important roles in cellular adaptation to stress. In particular, ATF6 is known to drive beneficial effects including increased ER capacity, cell survival in the face of stress, and more recently evidence from our group and several others implicate ATF6 in beta cell compensatory proliferation in response to insulin demand. For…

From the public funding record at NIH RePORTER. Describes the funded project, not the reviews below.

Reviews

← All labs at Weill Medical Coll of Cornell Univ